Ventricular Pre‑excitation (Wolff‑Parkinson‑White Syndrome)
What is Ventricular pre‑excitation (WPW)?
Ventricular pre‑excitation, most commonly recognized as Wolff‑Parkinson‑White (WPW) syndrome, is a cardiac electrophysiology disorder in which an extra electrical pathway (called an accessory pathway or bundle of Kent) connects the atria and ventricles. This pathway bypasses the normal atrioventricular (AV) node delay, allowing impulses to reach the ventricles earlier than they should. The result is a characteristic “short PR interval” and a “delta wave” on an electrocardiogram (ECG). In many people the condition is completely benign, but in others it can precipitate rapid heart rhythms (tachyarrhythmias) that may cause dizziness, fainting, or even sudden cardiac arrest.
WPW is present from birth (congenital) and is not caused by lifestyle factors, although it can become clinically apparent at any age, most often in adolescents and young adults. The prevalence is approximately 0.1‑0.3 % of the general population.1
Common Causes
WPW itself is not caused by other diseases, but several conditions or situations can be associated with, or unmask, ventricular pre‑excitation:
- Congenital accessory pathways – the primary cause; the bundle of Kent is formed during fetal heart development.
- Genetic syndromes such as:
- PRKAG2 cardiomyopathy
- LAMP2 (Danon disease)
- Familial atrial fibrillation with WPW
- Structural heart disease (e.g., hypertrophic cardiomyopathy, Ebstein anomaly) – can coexist with accessory pathways.
- Myocardial infarction or cardiac surgery – rare, but scar tissue may create secondary accessory connections.
- Electrolyte disturbances (especially hypokalemia or hypermagnesemia) – may precipitate arrhythmias in patients who already have WPW.
- Drug effects – certain anti‑arrhythmic agents (e.g., digoxin, calcium channel blockers) can worsen conduction through an accessory pathway and are therefore avoided.
- Pregnancy – hormonal and hemodynamic changes can increase the frequency of AV‑nodal‑dependent arrhythmias, making pre‑excitation more symptomatic.
- Alcohol or stimulant use (cocaine, amphetamines) – can trigger rapid atrial rates that conduct over the accessory pathway.
- High‑intensity exercise – especially in athletes, it may reveal latent pre‑excitation due to increased sympathetic tone.
- Infectious myocarditis – inflammation may transiently alter conduction properties.
Associated Symptoms
Many people with WPW are asymptomatic and discover the condition incidentally on an ECG. When symptoms do appear, they are usually related to the tachyarrhythmias that the accessory pathway allows:
- Palpitations – sudden rapid heartbeats that may feel “fluttering” or “racing.”
- Dizziness or light‑headedness, especially during an episode.
- Syncope (fainting) – caused by a brief drop in cardiac output.
- Chest discomfort or pressure – often mistaken for angina.
- Shortness of breath (dyspnea) during or after a tachycardia episode.
- Fatigue or reduced exercise tolerance.
- In rare cases, sudden cardiac arrest due to ventricular fibrillation.
Symptoms may be triggered by caffeine, alcohol, stress, or sudden changes in body position.
When to See a Doctor
Although WPW can be harmless, you should seek medical evaluation if you experience any of the following:
- Frequent or prolonged palpitations lasting more than a few minutes.
- Episodes of fainting, near‑fainting, or sudden loss of consciousness.
- Chest pain that is new, worsening, or not explained by musculoskeletal causes.
- Shortness of breath at rest or with minimal activity.
- A family history of sudden cardiac death or known WPW.
- Any cardiac symptoms that begin after starting a new medication or supplement.
Prompt evaluation is especially important for children, adolescents, and athletes, because they often participate in activities that can provoke rapid heart rates.
Diagnosis
Diagnosing WPW involves a combination of clinical assessment, ECG interpretation, and sometimes invasive electrophysiology studies.
1. Resting 12‑lead Electrocardiogram (ECG)
- Short PR interval (<120 ms).
- Delta wave – a slurred upstroke of the QRS complex.
- Widened QRS (>110 ms) with abnormal morphology.
2. Ambulatory (Holter) Monitoring
Records heart rhythm over 24‑48 hours to detect intermittent pre‑excitation or tachycardia episodes that may not appear on a single ECG.
3. Exercise Stress Test
Helps determine whether pre‑excitation disappears with increased heart rate, which can suggest a lower‑risk pathway.
4. Electrophysiology Study (EPS)
- Invasive catheter‑based test that maps the exact location and properties of the accessory pathway.
- Assesses the pathway’s ability to conduct rapid atrial rates (dangerous in atrial fibrillation).
- Often performed in conjunction with catheter ablation.
5. Imaging (Echocardiogram, Cardiac MRI)
Used to rule out structural heart disease that may coexist with WPW, such as hypertrophic cardiomyopathy.
Treatment Options
Treatment strategies are individualized based on symptom severity, pathway properties, patient age, and lifestyle.
1. Lifestyle Modifications (Home Care)
- Limit caffeine, energy drinks, and other stimulants.
- Avoid excess alcohol and illicit drugs.
- Stay hydrated and maintain normal electrolyte balance.
- Practice stress‑reduction techniques (yoga, meditation, biofeedback).
- For athletes, discuss activity restrictions with a cardiologist; low‑to‑moderate intensity is usually safe.
2. Pharmacologic Therapy
Medication is reserved for patients who are symptomatic but not ideal candidates for ablation.
- Class Ia (e.g., quinidine) – slows conduction through the accessory pathway.
- Class Ic (e.g., propafenone, flecainide) – effective in preventing orthodromic AV‑reentrant tachycardia.
- Beta‑blockers or non‑dihydropyridine calcium‑channel blockers – useful for rate control in AV‑node‑dependent tachycardias but should be avoided in patients with atrial fibrillation that conducts rapidly over the accessory pathway.
- Acute termination of a supraventricular tachycardia:
- Vagal maneuvers (Valsalva, carotid sinus massage).
- IV adenosine – rapid IV push, contraindicated in atrial fibrillation with WPW.
3. Catheter Ablation
The definitive therapy for most symptomatic individuals.
- Radiofrequency (RF) or cryo‑ablation catheters are guided to the accessory pathway and destroy it.
- Success rates >95 % with a low (<1 %) risk of serious complications.
- Recommended for:
- Recurrent symptomatic tachycardia.
- High‑risk pathways (i.e., capable of rapid conduction during atrial fibrillation).
- Patients who wish to avoid lifelong medication.
4. Implantable Cardioverter‑Defibrillator (ICD)
Reserved for very high‑risk patients (e.g., documented ventricular fibrillation or WPW combined with severe cardiomyopathy). Most WPW patients do not require an ICD.
Prevention Tips
While you cannot prevent the congenital formation of an accessory pathway, you can reduce the likelihood of symptomatic episodes and associated complications:
- Maintain regular follow‑up with a cardiologist or electrophysiologist, especially after a new symptom or a change in activity level.
- Adhere to any prescribed medication schedule; never stop a drug abruptly without medical advice.
- Stay up to date on vaccinations (e.g., flu, COVID‑19) to avoid infection‑related myocarditis that could aggravate arrhythmias.
- Adopt a heart‑healthy diet rich in fruits, vegetables, whole grains, and lean protein; limit processed foods high in sodium and sugar.
- Monitor electrolytes if you have conditions that predispose you to imbalance (e.g., chronic diuretic use, kidney disease).
- Use caution with over‑the‑counter cold or weight‑loss medications that contain stimulants or sympathomimetic agents.
- If you are an athlete, obtain a sports‑clearance ECG and discuss any WPW findings with your medical team.
- Educate family members about recognizing warning signs, especially for children and teenagers.
Emergency Warning Signs
- Sudden loss of consciousness or fainting (syncope).
- Severe chest pain or pressure that does not improve with rest.
- Palpitations accompanied by shortness of breath, dizziness, or a feeling of impending doom.
- Rapid, irregular heartbeat that does not respond to vagal maneuvers or adenosine (possible atrial fibrillation with fast ventricular response).
- Sudden cardiac arrest – no pulse, not breathing, unresponsive (call emergency services immediately).
If any of these occur, seek emergency medical care or call 911 without delay.
Key Take‑aways
- Ventricular pre‑excitation (WPW) is a congenital extra electrical pathway that can cause rapid heart rhythms.
- Most people are asymptomatic, but when symptoms appear they often involve palpitations, dizziness, or fainting.
- Diagnosis is made primarily with a resting ECG; an electrophysiology study pinpoints the pathway for possible ablation.
- Catheter ablation offers a cure for the majority of symptomatic patients and is preferred over long‑term drug therapy.
- Recognize red‑flag symptoms and seek immediate care; early treatment lowers the risk of serious complications.
References:
1. Mayo Clinic. Wolff‑Parkinson‑White syndrome. https://www.mayoclinic.org.
2. American Heart Association. WPW – Clinical Presentation and Diagnosis. https://www.heart.org.
3. National Institutes of Health, National Heart, Lung, and Blood Institute. “Wolff‑Parkinson‑White Syndrome.” https://www.nhlbi.nih.gov.
4. Cleveland Clinic. WPW – Treatment Options. https://my.clevelandclinic.org.